Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients

D. Foschi, F. Corsi, A. Rizzi, E. Asti, V. Carsenzuola, T. Vago, M. Bevilacqua, P. Riva, E. Trabucchi

Research output: Contribution to journalArticle

Abstract

Background: Restrictive bariatric surgery causes weight loss through substantial decline of appetite with satiety after meals. Reduction of plasma ghrelin levels after Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding could contribute to these effects, although contradictory results have been reported. The only restrictive operation still not yet investigated is vertical banded gastroplasty (VBG). We studied the effects of VBG on basal plasma ghrelin levels and meal-mediated inhibition. Methods: 12 morbidly obese patients, 11 female and 1 male, were studied before and after VBG, when the BMI fell by 20%. The control group consisted of 6 lean volunteers. Active ghrelin was determined by RIA after overnight fasting and after the administration of a liquid meal. Results: Obese patients preoperatively had significantly lower basal plasma ghrelin levels than lean volunteers, and the meal did not inhibit ghrelin secretion. After VBG and 20% BMI loss, basal plasma ghrelin levels increased and the reduction caused by a meal recovered. Conclusions: Weight loss caused by VBG is associated with higher plasma ghrelin levels in obese patients. The operation restores the normal adaptation of the A- cells of the stomach to a meal.

Original languageEnglish
Pages (from-to)1129-1132
Number of pages4
JournalObesity Surgery
Volume15
Issue number8
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Gastroplasty
Ghrelin
Meals
Weight Loss
Volunteers
Stomach
Bariatric Surgery
Gastric Bypass
Appetite
Fasting
Control Groups

Keywords

  • Gastroplasty
  • Ghrelin
  • Morbid obesity
  • Stomach
  • Weight loss

ASJC Scopus subject areas

  • Surgery

Cite this

Foschi, D., Corsi, F., Rizzi, A., Asti, E., Carsenzuola, V., Vago, T., ... Trabucchi, E. (2005). Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obesity Surgery, 15(8), 1129-1132. https://doi.org/10.1381/0960892055002338

Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. / Foschi, D.; Corsi, F.; Rizzi, A.; Asti, E.; Carsenzuola, V.; Vago, T.; Bevilacqua, M.; Riva, P.; Trabucchi, E.

In: Obesity Surgery, Vol. 15, No. 8, 09.2005, p. 1129-1132.

Research output: Contribution to journalArticle

Foschi, D, Corsi, F, Rizzi, A, Asti, E, Carsenzuola, V, Vago, T, Bevilacqua, M, Riva, P & Trabucchi, E 2005, 'Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients', Obesity Surgery, vol. 15, no. 8, pp. 1129-1132. https://doi.org/10.1381/0960892055002338
Foschi D, Corsi F, Rizzi A, Asti E, Carsenzuola V, Vago T et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obesity Surgery. 2005 Sep;15(8):1129-1132. https://doi.org/10.1381/0960892055002338
Foschi, D. ; Corsi, F. ; Rizzi, A. ; Asti, E. ; Carsenzuola, V. ; Vago, T. ; Bevilacqua, M. ; Riva, P. ; Trabucchi, E. / Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. In: Obesity Surgery. 2005 ; Vol. 15, No. 8. pp. 1129-1132.
@article{a8118b40c43f4e0a93e547fb7c2df75a,
title = "Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients",
abstract = "Background: Restrictive bariatric surgery causes weight loss through substantial decline of appetite with satiety after meals. Reduction of plasma ghrelin levels after Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding could contribute to these effects, although contradictory results have been reported. The only restrictive operation still not yet investigated is vertical banded gastroplasty (VBG). We studied the effects of VBG on basal plasma ghrelin levels and meal-mediated inhibition. Methods: 12 morbidly obese patients, 11 female and 1 male, were studied before and after VBG, when the BMI fell by 20{\%}. The control group consisted of 6 lean volunteers. Active ghrelin was determined by RIA after overnight fasting and after the administration of a liquid meal. Results: Obese patients preoperatively had significantly lower basal plasma ghrelin levels than lean volunteers, and the meal did not inhibit ghrelin secretion. After VBG and 20{\%} BMI loss, basal plasma ghrelin levels increased and the reduction caused by a meal recovered. Conclusions: Weight loss caused by VBG is associated with higher plasma ghrelin levels in obese patients. The operation restores the normal adaptation of the A- cells of the stomach to a meal.",
keywords = "Gastroplasty, Ghrelin, Morbid obesity, Stomach, Weight loss",
author = "D. Foschi and F. Corsi and A. Rizzi and E. Asti and V. Carsenzuola and T. Vago and M. Bevilacqua and P. Riva and E. Trabucchi",
year = "2005",
month = "9",
doi = "10.1381/0960892055002338",
language = "English",
volume = "15",
pages = "1129--1132",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients

AU - Foschi, D.

AU - Corsi, F.

AU - Rizzi, A.

AU - Asti, E.

AU - Carsenzuola, V.

AU - Vago, T.

AU - Bevilacqua, M.

AU - Riva, P.

AU - Trabucchi, E.

PY - 2005/9

Y1 - 2005/9

N2 - Background: Restrictive bariatric surgery causes weight loss through substantial decline of appetite with satiety after meals. Reduction of plasma ghrelin levels after Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding could contribute to these effects, although contradictory results have been reported. The only restrictive operation still not yet investigated is vertical banded gastroplasty (VBG). We studied the effects of VBG on basal plasma ghrelin levels and meal-mediated inhibition. Methods: 12 morbidly obese patients, 11 female and 1 male, were studied before and after VBG, when the BMI fell by 20%. The control group consisted of 6 lean volunteers. Active ghrelin was determined by RIA after overnight fasting and after the administration of a liquid meal. Results: Obese patients preoperatively had significantly lower basal plasma ghrelin levels than lean volunteers, and the meal did not inhibit ghrelin secretion. After VBG and 20% BMI loss, basal plasma ghrelin levels increased and the reduction caused by a meal recovered. Conclusions: Weight loss caused by VBG is associated with higher plasma ghrelin levels in obese patients. The operation restores the normal adaptation of the A- cells of the stomach to a meal.

AB - Background: Restrictive bariatric surgery causes weight loss through substantial decline of appetite with satiety after meals. Reduction of plasma ghrelin levels after Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding could contribute to these effects, although contradictory results have been reported. The only restrictive operation still not yet investigated is vertical banded gastroplasty (VBG). We studied the effects of VBG on basal plasma ghrelin levels and meal-mediated inhibition. Methods: 12 morbidly obese patients, 11 female and 1 male, were studied before and after VBG, when the BMI fell by 20%. The control group consisted of 6 lean volunteers. Active ghrelin was determined by RIA after overnight fasting and after the administration of a liquid meal. Results: Obese patients preoperatively had significantly lower basal plasma ghrelin levels than lean volunteers, and the meal did not inhibit ghrelin secretion. After VBG and 20% BMI loss, basal plasma ghrelin levels increased and the reduction caused by a meal recovered. Conclusions: Weight loss caused by VBG is associated with higher plasma ghrelin levels in obese patients. The operation restores the normal adaptation of the A- cells of the stomach to a meal.

KW - Gastroplasty

KW - Ghrelin

KW - Morbid obesity

KW - Stomach

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=25844471508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844471508&partnerID=8YFLogxK

U2 - 10.1381/0960892055002338

DO - 10.1381/0960892055002338

M3 - Article

C2 - 16197784

AN - SCOPUS:25844471508

VL - 15

SP - 1129

EP - 1132

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 8

ER -